American Association for Cancer Research Annual Meeting

The latest news from AACR, including researcher interviews and physician perspective.

Meeting NewsPerspective

CAR-T plus atezolizumab safe, effective in refractory diffuse large B-cell lymphoma

May 4, 2020
Treatment with the anti-PD-L1 antibody atezolizumab after the chimeric antigen receptor T-cell therapy axicabtagene ciloleucel appeared safe and…
Meeting NewsPerspective

Off-the-shelf CAR T-cell therapy effective for advanced T-cell acute lymphoblastic leukemia

May 4, 2020
TruUCAR GC027 — a gene edited, investigational allogeneic chimeric antigen receptor T-cell therapy — showed efficacy for treatment of…
Meeting NewsPerspective

Novel CD19/CD22 bispecific CAR-T effective, safe for advanced pediatric ALL

May 1, 2020
A novel bispecific chimeric antigen receptor T-cell therapy appeared safe and effective for younger patients with relapsed or refractory acute…
Meeting NewsPerspective

Pemetrexed appears safe for maintenance therapy with pembrolizumab in metastatic nonsquamous NSCLC

May 1, 2020
The addition of pemetrexed plus platinum chemotherapy to the immune checkpoint inhibitor pembrolizumab showed manageable toxicity among patients…
Meeting News

Talazoparib fails to extend OS vs. chemotherapy in BRCA-mutated advanced breast cancer

May 1, 2020
Talazoparib did not significantly improve OS compared with physician’s choice of chemotherapy for patients with HER2-negative advanced breast…
Meeting News

NCI pivots some research activities to COVID-19 amid ‘unprecedented disruption’

April 30, 2020
NCI staff have identified opportunities to contribute to the fight against COVID-19 while striving to make sure cancer research continues, one of the…
Meeting NewsPerspective

Larotrectinib induces durable responses in TRK fusion cancers

April 30, 2020
Larotrectinib appeared highly effective for adults and children with tropomyosin receptor kinase fusion cancers, according to study results presented…
Meeting News

Multicancer blood test feasible for routine clinical care, could guide intervention

April 30, 2020
A minimally invasive, multicancer blood test demonstrated utility for screening and helping to guide management of individuals with no cancer…
Meeting NewsPerspective

Lorlatinib active in ALK-positive NSCLC, regardless of EML4-ALK variants

April 30, 2020
Lorlatinib appeared to be an effective treatment for non-small cell lung cancer with ALK resistance mutations, regardless of EML4-ALK variants…
Meeting NewsPerspective

Atezolizumab plus cobimetinib improves PFS in biliary tract cancer

April 29, 2020
Atezolizumab plus cobimetinib significantly prolonged PFS compared with atezolizumab alone among a cohort of patients with advanced biliary tract…

Meeting Calendar

AACR Annual Meeting

June 22, 2020 - June 24, 2020